Crestmont Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$530K Sell
1,257
-63
-5% -$25.1K 0.15% 55
2026
Q2
$478K Buy
1,320
+89
+7% +$30.5K 0.13% 58
2026
Q1
$433K Buy
1,231
+150
+14% +$53.5K 0.14% 64
2025
Q4
$354K Buy
1,081
+57
+6% +$18.1K 0.12% 62
2025
Q3
$289K Buy
1,024
+107
+12% +$31K 0.1% 68
2025
Q2
$256K Buy
917
+5
+0.5% +$1.42K 0.09% 65
2025
Q1
$284K Buy
+912
New +$269K 0.12% 57
2024
Q4
– Sell
-982
Closed -$316K – 79
2024
Q3
$316K Buy
982
+17
+2% +$5.56K 0.14% 54
2024
Q2
$302K Buy
+965
New +$283K 0.15% 52

Other funds holding AMGN

Crestmont Private Wealth's AMGN Position: Q3 2026 in Review

Crestmont Private Wealth reduced its Amgen (AMGN) stake by 4.8% in Q3 2026, selling an estimated $25.1K and leaving 1,257 shares worth $530K. The position accounts for 0.15% of the portfolio, ranked #55.

Crestmont Private Wealth first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Crestmont Private Wealth held 1,257 shares of Amgen worth $530K as of Q3 2026.
  • Crestmont Private Wealth sold 63 Amgen shares in Q3 2026, an estimated $25.1K.
  • Amgen made up 0.15% of Crestmont Private Wealth's portfolio in Q3 2026, its #55 holding.
  • Crestmont Private Wealth first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Crestmont Private Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.